| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.
|
Lancet Oncol
|
2008
|
23.93
|
|
2
|
[Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients].
|
Zhongguo Fei Ai Za Zhi
|
2005
|
1.38
|
|
3
|
The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial.
|
Support Care Cancer
|
2008
|
1.14
|
|
4
|
Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer.
|
J Biomed Biotechnol
|
2011
|
1.10
|
|
5
|
Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells.
|
J Cancer Res Clin Oncol
|
2010
|
1.05
|
|
6
|
Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.
|
J Mol Med (Berl)
|
2013
|
1.03
|
|
7
|
Fibronectin extra domain A (EDA) sustains CD133(+)/CD44(+) subpopulation of colorectal cancer cells.
|
Stem Cell Res
|
2013
|
1.00
|
|
8
|
DNA vaccine against tumor endothelial marker 8 inhibits tumor angiogenesis and growth.
|
J Immunother
|
2009
|
0.98
|
|
9
|
Stable RNA interference of hexokinase II gene inhibits human colon cancer LoVo cell growth in vitro and in vivo.
|
Cancer Biol Ther
|
2008
|
0.96
|
|
10
|
Association of pregnane X receptor with multidrug resistance-related protein 3 and its role in human colon cancer chemoresistance.
|
J Gastrointest Surg
|
2009
|
0.94
|
|
11
|
Knock-down of glutaminase 2 expression decreases glutathione, NADH, and sensitizes cervical cancer to ionizing radiation.
|
Biochim Biophys Acta
|
2013
|
0.93
|
|
12
|
ERCC5 promoter polymorphisms at -763 and +25 predict the response to oxaliplatin-based chemotherapy in patients with advanced colorectal cancer.
|
Cancer Biol Ther
|
2009
|
0.92
|
|
13
|
Endostatin suppresses colorectal tumor-induced lymphangiogenesis by inhibiting expression of fibronectin extra domain A and integrin α9.
|
J Cell Biochem
|
2011
|
0.90
|
|
14
|
Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial.
|
Support Care Cancer
|
2013
|
0.89
|
|
15
|
The extra domain A of fibronectin increases VEGF-C expression in colorectal carcinoma involving the PI3K/AKT signaling pathway.
|
PLoS One
|
2012
|
0.89
|
|
16
|
Expression of Tiam1 and VEGF-C correlates with lymphangiogenesis in human colorectal carcinoma.
|
Cancer Biol Ther
|
2009
|
0.88
|
|
17
|
Silencing fibronectin extra domain A enhances radiosensitivity in nasopharyngeal carcinomas involving an FAK/Akt/JNK pathway.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.86
|
|
18
|
αV integrin induces multicellular radioresistance in human nasopharyngeal carcinoma via activating SAPK/JNK pathway.
|
PLoS One
|
2012
|
0.86
|
|
19
|
Overexpression of microRNA-122 re-sensitizes 5-FU-resistant colon cancer cells to 5-FU through the inhibition of PKM2 in vitro and in vivo.
|
Cell Biochem Biophys
|
2014
|
0.85
|
|
20
|
Phosphorylated insulin-like growth factor 1 receptor is implicated in resistance to the cytostatic effect of gefitinib in colorectal cancer cells.
|
J Gastrointest Surg
|
2011
|
0.85
|
|
21
|
The effect of focal adhesion kinase gene silencing on 5-fluorouracil chemosensitivity involves an Akt/NF-kappaB signaling pathway in colorectal carcinomas.
|
Int J Cancer
|
2010
|
0.83
|
|
22
|
Influence of interleukin-28B polymorphism on progression to hepatitis virus-induced hepatocellular carcinoma.
|
Tumour Biol
|
2014
|
0.82
|
|
23
|
Silencing hexokinase II gene sensitizes human colon cancer cells to 5-fluorouracil.
|
Hepatogastroenterology
|
2009
|
0.82
|
|
24
|
Low expression of prolyl hydroxylase 2 is associated with tumor grade and poor prognosis in patients with colorectal cancer.
|
Exp Biol Med (Maywood)
|
2012
|
0.81
|
|
25
|
The E-cadherin (CDH1) -C160A polymorphism and colorectal cancer susceptibility: a meta-analysis.
|
DNA Cell Biol
|
2012
|
0.80
|
|
26
|
The impact of nutritional status, nutritional risk, and nutritional treatment on clinical outcome of 2248 hospitalized cancer patients: a multi-center, prospective cohort study in Chinese teaching hospitals.
|
Nutr Cancer
|
2013
|
0.80
|
|
27
|
Genetic association between PER3 genetic polymorphisms and cancer susceptibility: a meta-analysis.
|
Medicine (Baltimore)
|
2015
|
0.79
|
|
28
|
Semaphorin3F down-regulates the expression of integrin alpha(v)beta3 and sensitizes multicellular tumor spheroids to chemotherapy via the neuropilin-2 receptor in vitro.
|
Chemotherapy
|
2009
|
0.79
|
|
29
|
[Demethylation in the promoter area by the antisense of human DNA MTase gene].
|
Zhonghua Zhong Liu Za Zhi
|
2002
|
0.79
|
|
30
|
Antitumor mechanism of recombinant murine interleukin-12 vaccine.
|
Cancer Biother Radiopharm
|
2010
|
0.78
|
|
31
|
[A randomized, controlled, multicenter clinical trial comparing pemetrexed/cisplatin and gemcitabine/cisplatin as first-line treatment for advanced nonsquamous non-small cell lung cancer].
|
Zhongguo Fei Ai Za Zhi
|
2012
|
0.77
|
|
32
|
Genetic Association Between NFKBIA -881A>G Polymorphism and Cancer Susceptibility.
|
Medicine (Baltimore)
|
2015
|
0.77
|
|
33
|
Clinical implications of the tumor-infiltrating lymphocyte subsets in colorectal cancer.
|
Med Oncol
|
2013
|
0.77
|
|
34
|
Functional Analysis of SNPs in the ERCC5 Promoter in Advanced Colorectal Cancer Patients Treated With Oxaliplatin-Based Chemotherapy.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
35
|
Marked anti-tumor effects of CD8(+)CD62L(+) T cells from melanoma-bearing mice.
|
Immunol Invest
|
2014
|
0.75
|
|
36
|
Mitogen-Activated Protein Kinase Kinase 4 Gene Polymorphism and Cancer Risk.
|
Medicine (Baltimore)
|
2015
|
0.75
|
|
37
|
Erratum: Follicular CXCR5-expressing CD8(+) T cells curtail chronic viral infection.
|
Nature
|
2016
|
0.75
|
|
38
|
[Efficacy of combined gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer].
|
Zhongguo Fei Ai Za Zhi
|
2005
|
0.75
|